These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 32525969)
1. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology. Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969 [TBL] [Abstract][Full Text] [Related]
2. Application of the international system for reporting serous fluid cytopathology on pleural effusion cytology with paired pleural biopsy: A new insight and novel approach on risk of malignancy. Maleki Z; Graham AJ; Jones R; Pastorello R; Morris P; Schmitt AC; Rodriguez EF Cytopathology; 2024 Nov; 35(6):695-705. PubMed ID: 39091111 [TBL] [Abstract][Full Text] [Related]
3. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center. Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444 [TBL] [Abstract][Full Text] [Related]
4. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions. Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633 [TBL] [Abstract][Full Text] [Related]
5. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology. Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631 [TBL] [Abstract][Full Text] [Related]
6. Real-World Evidence of Intra-institutional Performance Variation in Indefinite Diagnosis of Pleural Effusion Cytology. Chen KH; Kuo CY; Chen TD Arch Pathol Lab Med; 2024 Aug; 148(8):938-944. PubMed ID: 38031811 [TBL] [Abstract][Full Text] [Related]
7. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708 [TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid. Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884 [TBL] [Abstract][Full Text] [Related]
9. Serous effusions in malignant lymphomas: a review. Das DK Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559 [TBL] [Abstract][Full Text] [Related]
10. A 2-year retrospective study on pleural effusions: A cancer centre experience. Valerio E; Nunes W; Cardoso J; Santos A; Bovolim G; Domingos T; De Brot L; Saieg M Cytopathology; 2019 Nov; 30(6):607-613. PubMed ID: 31306514 [TBL] [Abstract][Full Text] [Related]
11. [Thoracocentesis for the assessment of lung cancer with pleural effusion]. Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions. Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747 [TBL] [Abstract][Full Text] [Related]
13. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Awasthi A; Gupta N; Srinivasan R; Nijhawan R; Rajwanshi A Cytopathology; 2007 Feb; 18(1):28-32. PubMed ID: 17250600 [TBL] [Abstract][Full Text] [Related]
14. Value of Ki67 immunostain in identification of malignancy in serous effusions. Saleh H; Bober P; Tabaczka P Diagn Cytopathol; 1999 Jan; 20(1):24-8. PubMed ID: 9884823 [TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology. Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334 [TBL] [Abstract][Full Text] [Related]
16. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Ong KC; Indumathi V; Poh WT; Ong YY Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675 [TBL] [Abstract][Full Text] [Related]
17. Reassessing the optimal volume for malignancy detection in serous fluid cytology. Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659 [TBL] [Abstract][Full Text] [Related]
18. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions. Hou T; Landon G; Stewart J; Roy-Chowdhuri S Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259 [TBL] [Abstract][Full Text] [Related]
19. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience. Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902 [TBL] [Abstract][Full Text] [Related]
20. Investigating unilateral pleural effusions: the role of cytology. Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]